BioSpace News Archive

CASI Pharmaceuticals, Inc. announces that the China National Medical Product Administration, has approved the clinical trial applications for CNCT19 in relapsed/refractory B-cell acute lymphoblastic leukemia and relapsed/refractory B-cell non-Hodgkin lymphoma submitted by its partner Juventas Cell Therapy Ltd., a biopharmaceutical company focused on cell therapy.

Misinterpretation of scans and films—particularly CT scans—is the leading cause of patient injury involving diagnostic radiologists, according to a new study by The Doctors Company.

For the first time ever, St. Jude Children’s Research Hospital® has partnered with Facebook to launch the St. Jude Hall of Heroes, a virtual reality experience inspired by St. Jude patients and brought to life by creative agencies BBDO New York and Flight School.

SparingVision awarded First Prize in the Biotech category during the European EIT Health Summit held in Paris from 2 to 3 December

Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation for cell line engineering, announced that it has entered into a partnership with The Human Protein Atlas.